跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMIWOK amikacin (as sulfate) 500mg/2mL solution for injection infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
AMIWOK amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
Approved
STANDARD
AMIWOK amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
Wockhardt Bio Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
851b1d90d23ba15e
Company
Wockhardt Bio Pty Ltd
Type
Standard
Approval Details
Approval Id
851b1d90d23ba15e
Product Name
AMIWOK amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
Artg Id
289081
Artg Name
AMIWOK amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
Sponsor
Wockhardt Bio Pty Ltd
Company Detail Path
/organization/wockhardt-bio-pty-ltd
Artg Date
2018-02-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/952732c5405d54aca671d1dd1c1a6332.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9cf709d731a38fecc0a4a6f35cf27ff5.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
851b1d90d23ba15e
Type
Standard
Back to TGA Approvals